S2 - Neuroimaging in MS

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): MS and CNS Inflammatory Disease
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome Naila Makhani, MD
Dr. Makhani has nothing to disclose.

1:12 PM 002 Longitudinal Assessment of Cervical Cord Atrophy Across MS Clinical Phenotypes: A Multicenter Study Maria A. Rocca
Dr. Rocca has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, Novartis, Teva Neurosciences and Genzyme.

1:24 PM 003 Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis Regina Schlaeger
Dr. Schlaeger has nothing to disclose.

1:36 PM 004 Thalamic MRI and histopathologic correlations in advanced multiple sclerosis Kedar Mahajan
Dr. Mahajan has nothing to disclose.

1:48 PM 005 In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg
Dr. Granberg has nothing to disclose.

2:00 PM 006 Structural Connectivity Shapes Patterns of Cortical Atrophy in Multiple Sclerosis Kevin Patel, MD
Dr. Patel has nothing to disclose.

2:12 PM 007 Prevalence of Leptomeningeal Contract Enhancement in Multiple Sclerosis Versus Other Chronic Neuroinflammatory Diseases Martina Absinta, MD
Dr. Absinta has nothing to disclose.

2:24 PM 008 Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Post-Contrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis Deepa Ramasamy
Dr. Zivadinov has received personal compensation for activities compensation for consulting, serving on a scientific advisory board, speaking, or other activities with EMD Serono, Genzyme, and Novartis. Dr. Zivadinov has received personal compensation in an editorial capacity for BioMed Res Int, BMC Med, BMC Neurol, Clinical CNS Drugs, Conf Pap Neurosci, J Alzh Dis, Vein and Lymphatics, and Word J Surg Proc. Dr. Zivadinov has received research support from Biogen Idec, Claret Medical, Genzyme, Intekrin-Coherus Novartis, and Teva Pharmaceuticals.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses